NIOX Group PLCLSE: NIOX

NIOX Group: Result of General Meeting

· Issued by NIOX Group PLC via RNS

Summary by 6ix AI

NIOX Group plc, a medical device company focused on point-of-care FeNO (exhaled nitric oxide) testing for asthma and COPD (chronic obstructive pulmonary disease), said shareholders passed the Tender Offer Resolution, relating to a tender offer (an offer to buy shares from shareholders), on a poll at its General Meeting held on October 21, 2026.

Key details

  • Votes for the resolution were 297,460,912 (99.17% of votes cast) and votes against were 2,502,197 (0.83%).
  • 1,881 votes were withheld; a withheld vote is not a vote in law and is not counted in the for and against proportions.

What’s still pending

  • The results of the Tender Offer will be announced on October 22, 2026.

6ix AI wrote this summary from the release below and checked it against the release.

On 6ix: 6ix.com/news/result-of-general-meeting-531

Niox Group PLC
21 October 2026
 

NIOX GROUP PLC

(the "Company" or the "Group")

Result of General Meeting

Oxford, UK – 21 October 2026: NIOX Group plc (AIM: NIOX), a medical device company focused on point-of-care FeNO testing for the diagnosis, monitoring and management of asthma and COPD, is pleased to announce that at the General Meeting of the Company held earlier today, the Tender Offer Resolution, as set out in the Notice of the General Meeting, was duly passed on a poll of votes. The number of total votes received from Shareholders by the Company were cast as follows:

Resolution

For

%

Against

%

Withheld

Tender Offer Resolution

 297,460,912

99.17

 2,502,197

0.83%

 1,881

Note: A vote "Withheld" is not a vote in law and is not counted in the calculation of the proportion of the votes "For" and "Against" shown.

The results of the Tender Offer will be announced on 22 October 2026.

Capitalised terms in this announcement (unless otherwise defined) have the same meanings as set out in the Circular. 

Contacts:

NIOX Group plc

Jonathan Emms, Chief Executive Officer

Sarah Duncan, Chief Financial Officer

+44 (0) 3303 309 356

Singer Capital Markets (Nominated Adviser and Broker)

Jen Boorer / James Fischer / Patrick Weaver 

+44 (0) 20 7496 3000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

NIOX Group PLC on 6ix

Story so far

Earlier from NIOX

Later from NIOX

All NIOX news releases